Praxis Precision
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (16)
Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Started: 1/29/2026
A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Started: 7/9/2025
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
Started: 8/13/2025
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Started: 10/27/2025
Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)
Started: 11/2/2023
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
Started: 12/11/2024
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Started: 1/10/2025
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)
Started: 8/2/2023
A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor
Started: 10/14/2021
A Clinical Trial of PRAX-944 in Participants With Essential Tremor
Started: 3/3/2020
A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
Started: 1/25/2022
A Clinical Trial of PRAX-114 in Participants With Essential Tremor
Started: 4/5/2022
A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder
Started: 6/24/2021
A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder
Started: 3/30/2021
A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Started: 4/13/2023
A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628
Started: 3/24/2025